First-time generic approvals July 2010

Generic drugs approved by FDA (through June 2010): Venlafaxine hydrochloride extended-release capsules, Meropenem for injection, Adapalene 0.1% gel, Aztreonam for injection, Oxaliplatin for injection

Venlafaxine hydrochloride extended-release capsules (equiv to Effexor XR) in 37.5-mg, 75-mg, and 150-mg strengths

TEVA

Meropenem for injection (equiv to Merrem) in 500-mg and 1-g vials

Adapalene 0.1% gel (equiv to Differin)

TEVA

Aztreonam for injection (equiv to Azactam) in single-dose vials of 1 g, 20 mL and 2 g, 30 mL

APP PHARMACEUTICALS

Oxaliplatin for injection (lyophilized) (equiv to Eloxatin), 50 mg and 100 mg

APP PHARMACEUTICALS